Eli Lilly (pharmaceutical company)Lǐlái Zhìyào礼来制药for / at (a price)yǐ以up to / at mostzuìgāo最高$3.8 billion38 yì měiyuán38亿美元to acquire / acquisitionshōugòu收购psychoactive drug / psychedelic medicinejīngshén huóxìng yàowù精神活性药物companygōngsī公司，to trigger / to sparkyǐnfā引发industryhángyè行业overall / as a wholezhěngtǐ整体revaluation / repricingchónggū重估。
Eli Lilly (pharmaceutical company)
Lǐlái Zhìyào
礼来制药
for / at (a price)
yǐ
以
up to / at most
zuìgāo
最高
$3.8 billion
38 yì měiyuán
38亿美元
to acquire / acquisition
shōugòu
收购
psychoactive drug / psychedelic medicine
jīngshén huóxìng yàowù
精神活性药物
company
gōngsī
公司
to trigger / to spark
yǐnfā
引发
industry
hángyè
行业
overall / as a whole
zhěngtǐ
整体
revaluation / repricing
chónggū
重估
Eli Lilly (pharmaceutical company)
Lǐlái Zhìyào
礼来制药
July 17
7 yuè 17 rì
7月17日
to announce
xuānbù
宣布
will (future marker)
jiāng
将
for / at (a price)
yǐ
以
up to / at most
zuìgāo
最高
$3.8 billion
38 yì měiyuán
38亿美元
to acquire
shōugòu
收购
psychoactive compound / psychedelic compound
jīngshén huóxìng huàhéwù
精神活性化合物
biotechnology company
shēngwù jìshù gōngsī
生物技术公司
AtaiBeckley (biotech company)
AtaiBeckley
AtaiBeckley
passive marker
bèi
被
within the industry
yè nèi
业内
to regard as
shì wéi
视为
traditional / conventional
chuántǒng
传统
large-scale / major
dàxíng
大型
pharmaceutical capital
zhìyào zīběn
制药资本
officially
zhèngshì
正式
to enter / to advance into
jìnjūn
进军
this field / this domain
gāi lǐngyù
该领域
structural particle
de
的
historic
lìshǐxìng
历史性
signal / indicator
xìnhào
信号
deal news / transaction news
jiāoyì xiāoxi
交易消息
to announce / to release
gōngbù
公布
after
hòu
后
in the same field / sector
tóng lǐngyù
同领域
multiple / many
duō jiā
多家
listed company / public company
shàngshì gōngsī
上市公司
stock price / share price
gǔjià
股价
significantly / by a large margin
dàfú
大幅
to rebound / to bounce back
fǎntán
反弹
psychoactive drug / psychedelic
jīngshén huóxìng yàowù
精神活性药物
sector / segment
bǎnkuài
板块
overall / as a whole
zhěngtǐ
整体
valuation
gūzhí
估值
to face / to confront
miànlín
面临
repricing / to be repriced
chóngxīn dìngjià
重新定价
July 18, 2026 at 9:30 AM
Eli Lilly (pharmaceutical company)
Lǐlái Zhìyào
礼来制药
on / at (formal)
yú
于
July 17
7 yuè 17 rì
7月17日
to announce
xuānbù
宣布
will (future marker)
jiāng
将
for / at (a price)
yǐ
以
up to / at most
zuìgāo
最高
$3.8 billion
38 yì měiyuán
38亿美元
structural particle
de
的
transaction consideration / deal price
jiāoyì duìjià
交易对价
to complete
wánchéng
完成
on / for
duì
对
biotechnology company
shēngwù jìshù gōngsī
生物技术公司
AtaiBeckley (biotech company)
AtaiBeckley
AtaiBeckley
structural particle
de
的
acquisition
shōugòu
收购
this
zhè
这
passive marker
bèi
被
within the industry
yè nèi
业内
generally / widely
pǔbiàn
普遍
to regard as / to consider
shì wéi
视为
large / large-scale
dàxíng
大型
pharmaceutical enterprise
zhìyào qǐyè
制药企业
officially / formally
zhèngshì
正式
to enter / to advance into
jìnjūn
进军
psychoactive drug / psychedelic
jīngshén huóxìng yàowù
精神活性药物
field / domain
lǐngyù
领域
structural particle
de
的
landmark / symbolic
biāozhìxìng
标志性
event
shìjiàn
事件
AtaiBeckley (biotech company)
AtaiBeckley
AtaiBeckley
structural particle
de
的
research pipeline
yánjiū guǎnxiàn
研究管线
centered on / using
yǐ
以
psilocybin (psychedelic compound)
Sàiluòxībīn
赛洛西宾
and / as well as
jí
及
other
qítā
其他
new type / novel
xīnxíng
新型
psychoactive
jīngshén huóxìng
精神活性
compound / chemical compound
huàhéwù
化合物
as the core / centered on
wéi héxīn
为核心
mainly / primarily
zhǔyào
主要
targeting / aimed at
zhēnduì
针对
severe depression / major depressive disorder
zhòngdù yìyù
重度抑郁
post-traumatic stress disorder (PTSD)
chuāngshāng hòu yìngjī zhàng ài
创伤后应激障碍
etc. / and so on
děng
等
treatment-resistant / refractory
nán zhì xìng
难治性
psychiatric disease / mental disorder
jīngshén jíbìng
精神疾病
to develop
kāifā
开发
alternative
tìdàixìng
替代性
therapy / treatment
liáofǎ
疗法
industry insiders / people in the field
yè nèi rénshì
业内人士
to point out / to note
zhǐchū
指出
in the past
guòqù
过去
half a century
bàn gè shìjì
半个世纪
since / over the past
yǐlái
以来
mainstream
zhǔliú
主流
pharmaceutical
zhìyào
制药
capital
zīběn
资本
always / consistently
shǐzhōng
始终
toward / regarding
duì
对
psychoactive drug / psychedelic
jīngshén huóxìng yàowù
精神活性药物
field / domain
lǐngyù
领域
to maintain / to keep
bǎochí
保持
a wait-and-see attitude
guānwàng tàidù
观望态度
this time
cǐ cì
此次
acquisition
shōugòu
收购
to mean / to signify
yìwèizhe
意味着
this
zhè yī
这一
situation / landscape
júmiàn
局面
passive marker
bèi
被
thoroughly / completely
chèdǐ
彻底
to break / to shatter
dǎpò
打破
driven by / due to
shòu
受
positive news / bullish news
lìhǎo xiāoxi
利好消息
driven by / propelled by
qūdòng
驱动
Compass Pathways (biotech company)
Compass Pathways
Compass Pathways
stock price / share price
gǔjià
股价
on that day / the same day
dāng rì
当日
increase / rise
zhǎngfú
涨幅
approximately / about
yuē
约
7 percent
7%
7%
GH Research (biotech company)
GH Research
GH Research
increase / rise
zhǎngfú
涨幅
approximately
yuē
约
15 percent
15%
15%
psychoactive drug / psychedelic
jīngshén huóxìng yàowù
精神活性药物
sector / segment
bǎnkuài
板块
overall / as a whole
zhěngtǐ
整体
valuation
gūzhí
估值
immediately / thereupon
suíjí
随即
passive marker
bèi
被
to reprice / repricing
chóngxīn dìngjià
重新定价
this year in April
jīnnián 4 yuè
今年4月
US President
Měiguó zǒngtǒng
美国总统
Trump
Tèlǎngpǔ
特朗普
to sign
qiānshǔ
签署
executive order
xíngzhèng lìng
行政令
to require / to demand
yāoqiú
要求
Department of Health and Human Services
Wèishēng Bù
卫生部
through / via
tōngguò
通过
Advanced Research Projects Agency (ARPA-H)
xiānjìn yánjiū xiàngmù jīgòu
先进研究项目机构
to allocate funds
bōkuǎn
拨款
$50 million
5000 wàn měiyuán
5000万美元
designated / earmarked
zhuānxiàng
专项
to support
zhīchí
支持
each state / various states
gè zhōu
各州
to conduct / to carry out
kāizhǎn
开展
psychoactive drug / psychedelic
jīngshén huóxìng yàowù
精神活性药物
research
yánjiū
研究
US Food and Drug Administration (FDA)
Měiguó Shípǐn Yàopǐn Jiāndū Guǎnlǐjú
美国食品药品监督管理局
already
yǐ
已
for
wèi
为
multiple types of / various
duō zhǒng
多种
psychoactive compound / psychedelic compound
jīngshén huóxìng huàhéwù
精神活性化合物
to grant / to award
shòuyǔ
授予
Breakthrough Therapy designation
tūpòxìng zhìliáo rèndìng
突破性治疗认定
related / relevant
xiāngguān
相关
drug / medication
yàopǐn
药品
approval / review
shěnpī
审批
cycle / timeline
zhōuqī
周期
therefore / as a result
yīncǐ
因此
from
cóng
从
usual / typical
tōngcháng
通常
structural particle
de
的
6 to 12 months
6 zhì 12 gè yuè
6至12个月
significantly / by a large margin
dàfú
大幅
to compress to / to shorten to
yāsuō zhì
压缩至
1 to 2 months
1 zhì 2 gè yuè
1至2个月
analyst / analysts
fēnxīshī
分析师
generally / widely
pǔbiàn
普遍
to predict / to forecast
yùcè
预测
Eli Lilly
Lǐlái
礼来
this move / this action
cǐjǔ
此举
will (future marker)
jiāng
将
to trigger / to set off
chùfā
触发
a new round of
xīn yī lún
新一轮
mergers and acquisitions / M&A
bìnggòu
并购
wave / tide
làngcháo
浪潮
to prompt / to urge
cùshǐ
促使
other
qítā
其他
large-scale / major
dàxíng
大型
pharmaceutical company
yào qǐ
药企
to accelerate / to intensify
jiājǐn
加紧
in
zài
在
mental health
jīngshén jiànkāng
精神健康
treatment
zhìliáo
治疗
field / domain
lǐngyù
领域
to position strategically
bùjú
布局
intellectual property
zhīshì chǎnquán
知识产权
assets
zīchǎn
资产
however / nevertheless
rán ér
然而
some / certain
bùfen
部分
medical ethics scholars / bioethicists
yīxué lúnlǐ xuézhě
医学伦理学者
and / with
yǔ
与
patient advocacy organizations
huànzhě quányì zǔzhī
患者权益组织
regarding / about
duì
对
this type of / such
gāi lèi
该类
drug / medication
yàowù
药物
structural particle
de
的
long-term safety
chángqī ānquánxìng
长期安全性
insufficient data / data gaps
shùjù bùzú
数据不足
regulatory framework
jiānguǎn kuàngjià
监管框架
yet to be improved / pending refinement
shàng dài wánshàn
尚待完善
as well as / and
yǐjí
以及
after commercialization
shāngyèhuà hòu
商业化后
patient / patients
huànzhě
患者
accessibility / access
kě jí xìng
可及性
issue / problem
wèntí
问题
expressed / raised
biǎodá le
表达了
concern / worry
guānqiē
关切
News in English
BusinessEli Lilly Acquires Psychedelic Medicine Startup AtaiBeckley for Up to 3.8 Billion Dollars in Industry Watershed Moment
Eli Lilly announced on July 17 that it will acquire biotechnology company AtaiBeckley for up to $3.8 billion, seen by the industry as a historic signal of mainstream pharmaceutical capital formally entering this field. After the deal was announced, share prices of multiple companies in the same sector surged, with the psychedelic medicine segment facing a broad revaluation.
More in Business
Chinazhōngguó中国planjìhuà计划20262026 nián2026年artificial intelligenceAIAIchipxīnpiàn芯片production capacitychǎnéng产能triplefān sānbèi翻三倍。
China
zhōngguó
中国
plan
jìhuà
计划
2026
2026 nián
2026年
artificial intelligence
AI
AI
chip
xīnpiàn
芯片
production capacity
chǎnéng
产能
triple
fān sānbèi
翻三倍
China Targets Tripling AI Chip Production in 2026 to Counter Nvidia Dependence
Chinazhōngguó中国artificial intelligenceAIAIchipxīnpiàn芯片manufacturerszhìzàoshāng制造商revenueyíngshōu营收significantlydàfú大幅growzēngzhǎng增长。
China
zhōngguó
中国
artificial intelligence
AI
AI
chip
xīnpiàn
芯片
manufacturers
zhìzàoshāng
制造商
revenue
yíngshōu
营收
significantly
dàfú
大幅
grow
zēngzhǎng
增长
Chinese AI Chipmakers Report Soaring Revenue Growth in 2026 Earnings Season
United States / AmericanMěiguó美国July7 yuè7月Consumer Price Index (CPI)CPICPIonly / merelyjǐn仅to rise / to go upshēng升0.1 percent0.1%0.1%，interest rate hikejiā xī加息worry / concerndānyōu担忧to ease / to alleviatehuǎnjiě缓解。
United States / American
Měiguó
美国
July
7 yuè
7月
Consumer Price Index (CPI)
CPI
CPI
only / merely
jǐn
仅
to rise / to go up
shēng
升
0.1 percent
0.1%
0.1%
interest rate hike
jiā xī
加息
worry / concern
dānyōu
担忧
to ease / to alleviate
huǎnjiě
缓解
US July CPI Rises Just 0.1 Percent as Tame Inflation Data Boosts Markets
Trian Fund Management (investment firm)Tèlǐān Jījīn特里安基金to plan / planjìhuà计划to acquire / takeovershōugòu收购Wendys (fast-food chain)Wēndí温迪，stock pricegǔjià股价to rise / to go upshàngzhǎng上涨13 percent13%13%。
Trian Fund Management (investment firm)
Tèlǐān Jījīn
特里安基金
to plan / plan
jìhuà
计划
to acquire / takeover
shōugòu
收购
Wendys (fast-food chain)
Wēndí
温迪
stock price
gǔjià
股价
to rise / to go up
shàngzhǎng
上涨
13 percent
13%
13%
Trian Fund Prepares Bid to Take Wendys Private as Stock Jumps 13 Percent